Hospital Universitario Miguel Servet; Servicio Hematologia
About Hospital Universitario Miguel Servet; Servicio Hematologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital Universitario Miguel Servet; Servicio Hematologia
During the past decade, Hospital Universitario Miguel Servet; Servicio Hematologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis
2018-04-24
2020-01-16
Completed
530
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
2018-09-03
2022-02-07
Terminated
1,936
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
2019-06-27
2020-11-26
Completed
179
Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)
2022-03-08
2024-05-28
Recruiting
170
A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
2023-01-25
2026-10-02
Recruiting
33
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Miguel Servet; Servicio Hematologia"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hospital Universitario Miguel Servet; Servicio Hematologia
According to Clinical.Site data, the most researched conditions in "Hospital Universitario Miguel Servet; Servicio Hematologia" are
"B-cell Lymphoma" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Hospital Universitario Miguel Servet; Servicio Hematologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario Miguel Servet; Servicio Hematologia
Most popular intervention types in "Hospital Universitario Miguel Servet; Servicio Hematologia" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Rituximab" (3 trials), "CHOP" (2 trials), "Cyclophosphamide" (2 trials), "Placebo" (2 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario Miguel Servet; Servicio Hematologia
The vast majority of trials in "Hospital Universitario Miguel Servet; Servicio Hematologia" are
5 trials for "All" genders.
Clinical Trials Status at Hospital Universitario Miguel Servet; Servicio Hematologia
Currently, there are NaN active trials in "Hospital Universitario Miguel Servet; Servicio Hematologia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hospital Universitario Miguel Servet; Servicio Hematologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario Miguel Servet; Servicio Hematologia, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".